Titre:
  • Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma
Auteur:Dreyling, Martin; Vitolo, Umberto; Hiemeyer, Florian; Giurescu, Marius; Garcia-Vargas, José; Gorbatchevsky, Igor; Liu, Karl; Koechert, Carol; Peña, Barrett B.H.; Neves, Franck; Childs, Piér P.L.; Morschhauser, Krimo; Zinzani, Dominique; Bouabdallah, David; Bron, Sarit S.E.; Cunningham, Gregor E G; Assouline, Kim; Verhoef, Catherine; Linton, ; Thieblemont,
Informations sur la publication:Annals of oncology, 28, 9, page (2169-2178)
Statut de publication:Publié, 2017
Sujet CREF:Hématologie
Mots-clés:Copanlisib
Malignant lymphoma
PI3K inhibitor
Treatment
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdx289
info:scp/85028774120